Antimicrobial stewardship in high-risk febrile neutropenia patients.

Adrien ContejeanSalam AbbaraRyme ChentouhSophie AlvisetEric GrignanoNabil GastliAnne CasettaLise WillemsEtienne CanouïCaroline CharlierFrédéric PèneJulien CharpentierJeanne Reboul-MartyRui BatistaDidier BouscarySolen Kernéis

Published in: Antimicrobial resistance and infection control (2022)

Implementation of a multidisciplinary AMS program for high-risk neutropenic patients was associated with lower carbapenem and glycopeptide use and improved clinical outcomes.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
patient reported outcomes
pseudomonas aeruginosa
drug resistant
acinetobacter baumannii